Literature DB >> 27334101

T2* Relaxometry in Patients with Parkinson's Disease : Use of an Automated Atlas-based Approach.

Karl Egger1,2, Florian Amtage3,4,5, Shan Yang6,3, Markus Obmann6,3, Ralf Schwarzwald6,3, Lena Köstering3,4,5,7, Irina Mader6,3, Julia Koenigsdorf6,3, Cornelius Weiller3,4,5, Christoph P Kaller3,4,5, Horst Urbach6,3.   

Abstract

BACKGROUND: Magnetic resonance (MR) relaxometry is of increasing scientific relevance in neurodegenerative disorders but is still not established in clinical routine. Several studies have investigated relaxation time alterations in disease-specific areas in Parkinson's disease (PD), all using manually drawn regions of interest (ROI). Implementing MR relaxometry into the clinical setting involves the reduction of time needed for postprocessing using an investigator-independent and reliable approach. The aim of this study was to evaluate an automated, atlas-based ROI method for evaluating T2* relaxation times in patients with PD.
METHOD: Automated atlas-based ROI analysis of quantitative T2* maps were generated from 20 PD patients and 20 controls. To test for the accuracy of the atlas-based ROI segmentation, we evaluated the spatial overlap in comparison with manually segmented ROIs using the Dice similarity coefficient (DSC). Additionally, we tested for group differences using our automated atlas-based ROIs of the putamen, globus pallidus, and substantia nigra.
RESULTS: A good spatial overlap accuracy was shown for the automated segmented putamen (mean DSC, 0.64 ± 0.04) and was inferior but still acceptable for the substantia nigra (mean DSC, 0.50 ± 0.17). Based on our automated defined ROI selection, a significant decrease of T2* relaxation time was found in the putamen as well as in the internal and external globus pallidus in PD patients compared with healthy controls.
CONCLUSION: Automated digital brain atlas-based approaches are reliable, more objective and time-efficient, and therefore have the potential to replace the time-consuming manual drawing of ROIs.

Entities:  

Keywords:  Dice similarity coefficient; Magnetic resonance imaging; Parkinson’s disease; Region of interest; Relaxometry

Mesh:

Year:  2016        PMID: 27334101     DOI: 10.1007/s00062-016-0523-2

Source DB:  PubMed          Journal:  Clin Neuroradiol        ISSN: 1869-1439            Impact factor:   3.649


  20 in total

1.  Welcome to the genomic era.

Authors:  Alan E Guttmacher; Francis S Collins
Journal:  N Engl J Med       Date:  2003-09-04       Impact factor: 91.245

Review 2.  Biomarkers in Parkinson's disease: an update.

Authors:  Alexander Shtilbans; Claire Henchcliffe
Journal:  Curr Opin Neurol       Date:  2012-08       Impact factor: 5.710

3.  Predicting planning performance from structural connectivity between left and right mid-dorsolateral prefrontal cortex: moderating effects of age during postadolescence and midadulthood.

Authors:  Christoph P Kaller; Marco Reisert; Michael Katzev; Roza Umarova; Irina Mader; Jürgen Hennig; Cornelius Weiller; Lena Köstering
Journal:  Cereb Cortex       Date:  2013-10-09       Impact factor: 5.357

4.  Spatial normalization, bulk motion correction and coregistration for functional magnetic resonance imaging of the human cervical spinal cord and brainstem.

Authors:  Patrick W Stroman; Chase R Figley; Catherine M Cahill
Journal:  Magn Reson Imaging       Date:  2008-05-21       Impact factor: 2.546

Review 5.  Milestones in Parkinson's disease--clinical and pathologic features.

Authors:  Glenda Halliday; Andrew Lees; Matthew Stern
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

6.  Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla.

Authors:  R J Ordidge; J M Gorell; J C Deniau; R A Knight; J A Helpern
Journal:  Magn Reson Med       Date:  1994-09       Impact factor: 4.668

7.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

8.  Measuring iron in the brain using quantitative susceptibility mapping and X-ray fluorescence imaging.

Authors:  Weili Zheng; Helen Nichol; Saifeng Liu; Yu-Chung N Cheng; E Mark Haacke
Journal:  Neuroimage       Date:  2013-04-13       Impact factor: 6.556

9.  Midbrain iron content in early Parkinson disease: a potential biomarker of disease status.

Authors:  W R Wayne Martin; Marguerite Wieler; Myrlene Gee
Journal:  Neurology       Date:  2008-01-02       Impact factor: 9.910

10.  In vivo quantitative susceptibility mapping (QSM) in Alzheimer's disease.

Authors:  Julio Acosta-Cabronero; Guy B Williams; Arturo Cardenas-Blanco; Robert J Arnold; Victoria Lupson; Peter J Nestor
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

View more
  1 in total

Review 1.  Rapid MR relaxometry using deep learning: An overview of current techniques and emerging trends.

Authors:  Li Feng; Dan Ma; Fang Liu
Journal:  NMR Biomed       Date:  2020-10-15       Impact factor: 4.478

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.